Go to GoReading for breaking news, videos, and the latest top stories in world news, business, politics, health and pop culture.

25-Hydroxyvitamin D and Cognitive Impairment, Dementia Risk

109 32
25-Hydroxyvitamin D and Cognitive Impairment, Dementia Risk

Abstract and Introduction

Abstract


Objective The association of low vitamin D status with mild cognitive impairment (MCI), a preclinical condition that can lead to dementia, has not yet been fully explored. Our aim was to investigate the association between vitamin D status and the future risk of MCI and dementia in older adults.

Design, setting and participants We conducted a population-based prospective study as a part of the Korean Longitudinal Study on Health and Aging. Four hundred and twelve elderly participants who completed evaluations of cognitive function and metabolic parameters in 2005–2006 and 2010–2011 were analysed.

Major outcome measure The rate of development of MCI or dementia during the study period was compared according to baseline vitamin D status. Binary logistic regression analysis was performed to investigate any independent association between vitamin D status and the risks of MCI or dementia.

Results Among 405 subjects that remained after excluding seven demented subjects at baseline, 338 subjects remained unchanged or improved in their diagnosis for cognitive function during the study period, whereas 67 subjects showed progression to MCI or dementia. When analyzing 236 subjects whose baseline mini-mental state examination (MMSE) scores were <27, severe vitamin D deficiency at baseline, defined as <25 nmol/l, was independently associated with the progression of cognitive impairment. Among 297 subjects who were normal at baseline, 50 acquired MCI and 247 remained normal. Severe vitamin D deficiency was also independently associated with the development of MCI when analyzing 145 subjects whose baseline MMSE scores were <27.

Conclusion Severe vitamin D deficiency was independently associated with the future risk of MCI as well as dementia, especially in older adults whose baseline MMSE scores had decreased only modestly.

Introduction


Vitamin D status is determined by the serum level of 25-hydroxyvitamin D, or 25 (OH) D; and a low vitamin D status is common and considered as a major health problem in elderly populations. Several studies have reported that low vitamin D status is associated with poor bone health and other conditions including cardiovascular diseases, insulin resistance, autoimmune diseases and certain malignancies. Therefore, vitamin D is now considered to play an important role in muscle function, immunity, metabolic signalling and protection against cardiovascular diseases and malignancies.

The global population is ageing, and the prevalence and economic burdens of dementia are rapidly increasing worldwide as well as in Korea. Low vitamin D status has also received attention as a potential metabolic risk factor for dementia. A number of studies have shown that a low serum 25 (OH) D concentration was associated with an increased risk of dementia and Alzheimer's disease in older adults. However, the association of low vitamin D status with mild cognitive impairment (MCI), a preclinical condition that can lead to dementia, has not yet been fully explored. Considering the possibility of 'critical periods' at older ages during which an adequate vitamin D level might prevent neurocognitive loss, it is important to evaluate any association of low vitamin D status with MCI so that we can screen and manage low vitamin D status in the elderly as early as possible to reduce the future risk of dementia.

Here, we investigated the association between vitamin D status and the future risk of MCI and dementia in a population-based prospective cohort of Korean elders. Comprehensive cognitive domains with other potential confounding factors that could affect cognitive function were examined.

Source...

Leave A Reply

Your email address will not be published.